InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Mats Lek. Officer active across 1 company, notably Swedish Orphan Biovitrum AB (publ). Cumulatively, 2 disclosures have been recorded. History available since 12 June 2026. The latest transaction was disclosed on 12 June 2026 (Purchase). Regulator: FIN-FSA. The full history is openly available.
2 of 2 declarations